Please feel free to read or download published articles written by or relating to GRA. If you re-publish or use any excerpts from the articles, please remember to cite GRA or the author.
Public-Private Coalition's: High-Profile Delinkage Policy For Emerging Vaccines
2017 article about CEPI's Public-Private Coalition's High-Profile Delinkage Policy For Emerging Vaccines.Read this article
The Analyst’s Perspective: Ensuring and Controlling Quality of Well-Characterized Biologics
Read GRA's contribution to Bioprocess International's 'The State of the Industry' articles exploring use of statistics in the sector.Read this article
Balancing the statistical tightrope
During one development meeting early in my industrial career, a process development group member asked me whether the value my group had reported in one result was okay to use. I con dently replied “Yes, it’s ne. It’s about 40, somewhere between 38 and 42. The other person raised his eyebrows. “About 40?” In response, I somewhat awkwardly mumbled “Yes, probably . . . about that” – an answer not met with full understanding, but rather concern.Read this article